Skip to content

Evaluating Infrasonic Hemodynography

Clinical Correlation of a Novel Wearable Sensor to Detect Cardiovascular Mechanical and Electrical Properties Through Infrasonic Hemodynography

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04636892
Enrollment
25
Registered
2020-11-19
Start date
2021-01-04
Completion date
2025-12-01
Last updated
2024-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Stenosis, Cardiovascular Diseases, Coronary Artery Disease, Heart Failure, Systolic, Mitral Regurgitation, Pulmonary Hypertension

Keywords

infrasonic hemodynography, biomedical device

Brief summary

This comparative diagnostic accuracy study will determine the accuracy of a noninvasive wearable infrasonic sensor to detect the mechanical, electrical, and hemodynamic function of the cardiovascular system.

Detailed description

This comparative diagnostic accuracy study will determine the accuracy of a noninvasive wearable infrasonic sensor to detect the mechanical, electrical, and hemodynamic function of the cardiovascular system. 25 patients with cardiovascular disease will undergo a comprehensive echocardiogram, electrocardiogram, and cardiac catheterization while wearing a infrasonic earbud device. The infrasonic and hemodynamic waveforms will be analyzed using machine learning with the goal of correlating infrasound data captured by the earbud to the patient's cardiovascular hemodynamics.

Interventions

OTHERMindMics earbud

Novel noninvasive wearable infrasound sensor

Sponsors

Scripps Health
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Normal Sinus Rhythm * LV systolic function \>53%

Exclusion criteria

* 1\. Known history of carotid artery disease * 2\. Moderate or greater valvular disease in Group 1 * 3\. Other implantable devices (pacemaker, ICD, CardioMems, TENS unit, continuous glucose monitors, etc) * 4\. Active arrhythmia * 5\. Reduced Ejection Fraction (\< 35%) other than Group 4 * 6\. Hearing loss

Design outcomes

Primary

MeasureTime frameDescription
Infrasound Hemodynography1 yearCorrelation of Infrasound data to hemodynamic parameter(s) and to cardiac time intervals

Countries

United States

Contacts

Primary ContactCarly Waldman, MD
waldman.carly@scrippshealth.org858-537-7792
Backup ContactSanjeev Bhavnani, MD
bhavnani.sanjeev@scrippshealth.org619-660-1842

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026